Header cover image

U.S. Pharmaceuticals & Biotech Buy the Dip

UPDATED Apr 22, 2024

Companies which may present a buying opportunity after a dip in share price.

102 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

XERS

Xeris Biopharma Holdings		US$1.78-1.1%-19.5%US$250.0mUS$4.75PS1.5xE62.1%n/a

AMRN

Amarin		US$0.87-3.4%-32.4%US$355.5mUS$1.08PS1.2xE51.1%n/a

BGNE

BeiGene		US$130.94-2.3%-46.9%US$13.7bUS$268.64PS5.6xE56.2%n/a

LFCR

Lifecore Biomedical		US$6.29-3.8%43.6%US$192.1mUS$6.00PS1.9xE138.1%n/a

MNKD

MannKind		US$4.111.5%5.7%US$1.1bUS$7.08PS5.6xE39.2%n/a

AUPH

Aurinia Pharmaceuticals		US$5.051.0%-54.4%US$730.3mUS$10.57PS4.2xE53.7%n/a

RIGL

Rigel Pharmaceuticals		US$1.13-0.9%0%US$198.2mUS$4.57PS1.7xE55.2%n/a

ATOS

Atossa Therapeutics		US$1.42-7.8%123.7%US$177.9mUS$4.58PB2xE66.0%n/a

BHC

Bausch Health Companies		US$8.45-3.3%18.7%US$3.1bUS$10.21PE-5.2xE93.4%n/a

IVVD

Invivyd		US$2.19-18.9%97.3%US$261.1mUS$9.38PB1.5xE65.1%n/a

ELAN

Elanco Animal Health		US$12.93-5.2%38.6%US$6.4bUS$17.24PS1.4xE91.3%n/a

BIO

Bio-Rad Laboratories		US$280.13-4.3%-35.9%US$8.0bUS$428.90PS3xE81.3%n/a

ASRT

Assertio Holdings		US$0.878.7%-83.9%US$82.3mUS$3.00PB0.6xE144.9%n/a

HBIO

Harvard Bioscience		US$3.70-11.5%-29.5%US$160.7mUS$7.00PS1.4xE98.9%n/a

PNT

POINT Biopharma Global		US$12.500.2%75.1%US$1.3bUS$12.50PE13.8xE9.2%n/a

MDXG

MiMedx Group		US$6.362.1%73.8%US$934.7mUS$12.44PE16.8xE15.0%n/a

PACB

Pacific Biosciences of California		US$1.5611.4%-84.7%US$424.8mUS$5.82PS2.1xE20.1%n/a

TVTX

Travere Therapeutics		US$5.85-4.9%-72.1%US$445.2mUS$14.64PS3.1xE62.8%n/a

BIIB

Biogen		US$194.11-0.5%-31.3%US$28.2bUS$290.83PE24.3xE18.2%n/a

ALDX

Aldeyra Therapeutics		US$3.921.3%-56.8%US$230.9mUS$9.57PB1.9xE61.0%n/a

MRNS

Marinus Pharmaceuticals		US$1.4822.9%-82.0%US$81.0mUS$8.78PS2.6xE56.1%n/a

LYRA

Lyra Therapeutics		US$5.21-3.5%157.9%US$311.3mUS$12.00PS199.8xE12.6%n/a

CGEN

Compugen		US$1.89-6.9%215.0%US$169.2mUS$5.33PS5.1xE-10.1%n/a

REPL

Replimune Group		US$6.42-10.2%-63.1%US$394.1mUS$13.56PB0.9xE28.0%n/a
Page 2 of 5
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.